Edwards Lifesciences (EW) EBITDA Margin (2009 - 2026)
Edwards Lifesciences (EW) recorded EBITDA Margin of 20.05% in Q3 2026, down 2.24 percentage points from 22.30% a year earlier and down 11.88 percentage points from the prior quarter.
Powered by 
Analysis
Edwards Lifesciences (EW) EBITDA Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Edwards Lifesciences' EBITDA Margin came in at 24.15% as of Sep 30, 2026, down 2.74 percentage points year-over-year; for FY2025, it came in at 23.42%, down 4.78 percentage points from FY2024.
- Annual EBITDA Margin has declined for three straight years, though with a five-year change of +0.51 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at 28.20% in FY2024 (-0.82 pp), 29.02% in FY2023 (-7.68 pp), 36.69% in FY2022 (+1.81 pp) and 34.88% in FY2021 (+11.97 pp).
- Quarterly EBITDA Margin has ranged from 12.35% in Q4 2025 to 54.22% in Q4 2022 over the past five years.
- On a year-over-year basis, EBITDA Margin rose in three of the last eight quarters, with an average year-over-year change of -2.72 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 23.58 percentage points in Q4 2022, against a drop of 23.94 percentage points in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 31.93% (Q2 2026), 31.45% (Q1 2026) and 12.35% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 266.22 Bn | 242.86 Bn | 5.13 Bn | 25.44% |
| 2 | Abbott Laboratories | 191.31 Bn | 165.77 Bn | 7.39 Bn | 20.09% |
| 3 | Danaher | 166.16 Bn | 145.82 Bn | 3.84 Bn | 30.00% |
| 4 | Intuitive Surgical | 155.98 Bn | 136.40 Bn | 2.08 Bn | 25.90% |
| 5 | Medtronic | 130.05 Bn | 96.18 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 123.40 Bn | 109.59 Bn | 4.25 Bn | - |
| 7 | Boston Scientific | 64.81 Bn | 60.48 Bn | 3.43 Bn | 23.14% |
| 8 | Edwards Lifesciences | 59.87 Bn | 43.18 Bn | 1.35 Bn | 20.05% |
| 9 | Medline | 53.84 Bn | 50.96 Bn | 1.93 Bn | 9.79% |
| 10 | Agilent Technologies | 50.15 Bn | 43.04 Bn | 1.04 Bn | 27.16% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 20.05% |
| Jun 30, 2026 | 31.93% |
| Mar 31, 2026 | 31.45% |
| Dec 31, 2025 | 12.35% |
| Sep 30, 2025 | 22.30% |
| Jun 30, 2025 | 29.32% |
| Mar 31, 2025 | 30.54% |
| Dec 31, 2024 | 25.63% |
| Sep 30, 2024 | 28.43% |
| Jun 30, 2024 | 29.66% |
| Mar 31, 2024 | 29.14% |
| Dec 31, 2023 | 30.28% |
| Sep 30, 2023 | 32.40% |
| Jun 30, 2023 | 23.43% |
| Mar 31, 2023 | 34.68% |
| Dec 31, 2022 | 54.22% |
| Sep 30, 2022 | 33.19% |
| Jun 30, 2022 | 35.93% |
| Mar 31, 2022 | 35.30% |
| Dec 31, 2021 | 30.64% |
API Access
Edwards Lifesciences EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=EW&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "EW", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=EW&period=max&api_key=YOUR_API_KEY");
const data = await res.json();